New robotic system for minimally invasive surgeries
A Novel Robotic Surgical System for Minimally Invasive Surgery: A Prospective, Single Center, Multi-speciality Study
This study is testing a new robotic system for minimally invasive surgeries to see if it can improve recovery and outcomes for patients with conditions like prostate and colorectal cancers.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong, Outside Of US & Canada) |
| Trial ID | NCT05151835 on ClinicalTrials.gov |
What this trial studies
This study evaluates a novel robotic surgical system designed for minimally invasive surgeries across various specialties, including urology and gastrointestinal procedures. It is a prospective single-center cohort study involving 20 patients who will undergo standardized robotic surgeries for conditions such as prostate and colorectal cancers. The study aims to assess clinical outcomes such as operative time, complications, hospital stay, and recovery rates. Participants will be monitored for their demographics and surgical performance metrics.
Who should consider this trial
Good fit: Ideal candidates are patients with a body mass index under 35 who require minimally invasive surgical treatment for specified conditions.
Not a fit: Patients with contraindications to general anesthesia or severe concomitant illnesses may not benefit from this study.
Why it matters
Potential benefit: If successful, this robotic system could enhance surgical precision and reduce recovery times for patients undergoing minimally invasive procedures.
How similar studies have performed: While robotic surgery has been widely studied, this specific robotic system's effectiveness is novel and untested in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Body mass index \<35 kg/m2 2. Suitable for the listed minimally invasive surgical procedures for treatment of respective diseases 3. Willingness to participate as demonstrated by giving informed consent Exclusion Criteria: 1. Contraindication to general anesthesia 2. Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention 3. Untreated active infection 4. Noncorrectable coagulopathy 5. Presence of another malignancy or distant metastasis 6. Emergency surgery 7. Vulnerable population (e.g. mentally disabled, pregnancy)
Where this trial is running
Hong Kong, Outside Of US & Canada
- Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong — Hong Kong, Outside Of US & Canada, China (Recruiting)
Study contacts
- Principal investigator: Simon SM Ng, MD — Chinese University of Hong Kong
- Study coordinator: Philip WY Chiu, MD
- Email: philipchiu@surgery.cuhk.edu.hk
- Phone: +85291252907
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.